| Issue |
Title |
File |
| Vol 10, No 9 (2024) |
Life, health, “life of disease” and the theory of general pathology |
|
|
Katz Y.A., Parkhonyuk E.V., Skriptsova S.A.
|
| Vol 10, No 1 (2024) |
Life quality and prognosis of patients with adverse post-infarction left ventricle remodeling |
|
|
Salyamova L.I., Kvasova O.G., Babkina I.A., Rymar V.V.
|
| Vol 11, No 5 (2025) |
Life quality in comorbid patients with atrial fibrillation and non-alcoholic fatty liver disease having hyperammoniemia |
|
|
Alekseenko S.A., Pan A.A., Zaikova-Khelimskaya I.V.
|
| Vol 10, No 2 (2024) |
Linear IgA-dependent bullous dermatosis as a rare type of vancomycin therapy complication: a clinical case |
|
|
Safronenko A.V., Gantsgorn E.V., Polyakova V.I., Gubin E.V., Rashkova E.V., Tuganov I.V.
|
| Vol 9, No 4 (2023) |
Lipid-lowering therapy today and tomorrow |
|
|
Boeva O.I., Kokorin V.A., Latiy V.V.
|
| Vol 10, No 4 (2024) |
Local therapy for osteoarthritis and periarticular soft tissue pathology: hyaluronic acid in focus |
|
|
Strebkova E.A., Alekseeva L.I.
|
| Vol 9, No 6 (2023) |
Lung damage in rheumatoid arthritis: complex points of clinical practice |
|
|
Beketova M.F., Georginova O.A., Krasnova T.N.
|
| Vol 11, No 4 (2025) |
Management of patients with insomnia (sleeplessness) in therapist’s outpatient practice |
|
|
Spektor E.D., Poluektov M.G.
|
| Vol 10, No 3 (2024) |
Manifestation of extraintestinal ulcerative colitis symptomatic after colectomy |
|
|
Valitova A.D., Galieva A.M., Mukhametova D.D., Belousova E.N., Cheremina N.A., Odintsova A.K.
|
| Vol 9, No 10 (2023) |
Meta-analysis of observational cohort studies on the relationships of asymptomatic hyperuricemia with chronic kidney disease |
|
|
Mazurov V.I., Drapkina O.M., Martynov A.I., Sayganov S.A., Bashkinov R.A., Gaydukova I.Z., Sapozhnikov K.V., Tolkacheva D.G., Sableva N.A., Tsinserling A.Y.
|
| Vol 10, No 5 (2024) |
Metabolic comorbidity in case of cerebrovascular pathology |
|
|
Antonova K.V., Lagoda O.V., Shishkina T.S., Tanashyan M.M.
|
| Vol 10, No 5 (2024) |
Metabolic markers of cerebrovascular pathology |
|
|
Tanashyan M.M., Antonova K.V., Spryshkov N.E., Panina A.A.
|
| Vol 11, No 6 (2025) |
Metabolic-associated fatty liver disease: difficulties in diagnostics and ways to overcome them |
|
|
Minosyan I.S., Tarasova O.I., Kokorin V.A.
|
| Vol 10, No 2 (2024) |
Metal nano- and microparticles-induced oral mucosa immunopathological inflammation |
|
|
Labis V.V., Bazikyan E.A., Sizova S.V., Khaidukov S.V., Zhigalina O.M., Khmelenin D.N., Dyachkova I.G., Zolotov D.A., Asadchikov V.E., Isakina M.O., Gildeeva G.N., Kozlov I.G.
|
| Vol 11, No 1 (2025) |
Methodological recommendations (draft). Systemic lupus erythematosus: Diagnosis, treatment, monitoring (short version) |
|
|
Popkova Т.V., Panafidina T.A., Lila A.M.
|
| Vol 9, No 2 (2023) |
MicroRNA-1 and microRNA-133: Small molecules of great importance in the aspect of cardiovascular diseases |
|
|
Aliyeva A.M., Teplova N.V., Butenko A.V., Averin E.E., Akhmedova M.F., Shikhova Y.A., Valiev R.K., Sariyev M.N., Kotikova I.A., Nikitin I.G.
|
| Vol 9, No 10 (2023) |
Mineral density bone tissue disorder in case of inflammatory bowel diseases (literature review) |
|
|
Abdulganieva D.I., Kupkenova L.M., Yangurazova A.R., Myasoutova E.R.
|
| Vol 9, No 2 (2023) |
Mixed infection with hepatitis A and E in combination with hemorrhagic fever with renal syndrome |
|
|
Shiryaeva M.A., Lebedeva N.N., Baranov A.E., Agarkova A.A., Malinnikova E.Y.
|
| Vol 9, No 8 (2023) |
Modern approaches to colorectal cancer screening and prevention |
|
|
Bakulin I.G., Zharkov A.V., Serkova M.Y., Zhuravleva M.S.
|
| Vol 11, No 2 (2025) |
Modern approaches to the diagnosis and treatment of sarcopenia in patients with chronic kidney disease |
|
|
Gasanov M.Z., Batyushin M.M., Veber V.R., Chulkov V.S., Azovtseva O.V.
|
| Vol 9, No 8 (2023) |
Modern aspects of the use of acetylsalicylic acid in pregnant women |
|
|
Chulkov V.S., Nikolenko E.S., Chulkov V.S., Okonenko T.I., Zhmaylova S.V.
|
| Vol 9, No 2 (2023) |
Modern aspects of the use of local hyaluronic acid in musculoskeletal diseases |
|
|
Strebkova E.A., Alekseeva L.I.
|
| Vol 9, No 8 (2023) |
Modern aspects of use of tirzepatide – the first dual agonist of glucagon-like peptide-1 and glucosependent insulinotropic peptide receptors |
|
|
Usanova A.A., Lavrenova E.A., Kunyaeva T.A., Kuzma F., Novikova E.K., Sergutova N.P., Chatkina T.A.
|
| Vol 9, No 4 (2023) |
Modern concepts concerning the mechanisms of iron absorption: activators, inhibitors, regulation, new possibilities of optimization |
|
|
Stuklov N.I., Gurkina A.A., Kovalchuk M.S., Kisly N.D.
|
| Vol 11, No 3 (2025) |
Modern concepts of pleiotropic effects of semaglutide in a wide population of patients |
|
|
Demidova T.Y., Teplova A.S., Izmailova M.Y.
|
| Vol 10, No 1 (2024) |
Modern methods of surgical treatment of patients with rheumatic diseases |
|
|
Makarov M.A., Roskidailo A.A.
|
| Vol 10, No 8 (2024) |
Modern opportunities for residual cardiovascular risk reducing |
|
|
Boeva O.I., Rzhevskaya E.V., Shkuta E.V., Baibuldin I.R., Drozdov V.V., Puchkova E.Y.
|
| Vol 9, No 4 (2023) |
Modern opportunities for treatment of patient having chronic heart failure with low ejection fraction |
|
|
Roitberg G.E., Ardashev A.V., Zhelyakov E.G., Kondratova N.V., Merzyavko L.K., Ponkina N.K., Slastnikova I.D., Sokolov D.V.
|
| Vol 11, No 1 (2025) |
Modern proton pump inhibitors: clinical advantages of esomeprazole |
|
|
Ketova G.G., Shamina O.M., Dolgushina A.I.
|
| Vol 9, No 5 (2023) |
Modern strategies for safety of iron deficiency pharmacotherapy improving |
|
|
Shikh E.V., Makhova A.A., Krasnoperova E.V.
|
| Vol 9, No 9 (2023) |
Modern viewpoint at prediabetes: Prevalence, diagnostic criteria, risk groups, screening |
|
|
Larina V.N., Lankin A.O., Larin V.G., Golovko M.G.
|
| Vol 9, No 8 (2023) |
More on the neuroprotectory therapy evidential base: focus at ethylmethyl hydroxypyridine succinate |
|
|
Kochetkov A.I., Shatalova N.A., Klepikova M.V., Filippova T.V., Ostroumova O.D.
|
| Vol 10, No 6 (2024) |
Mucoactive drugs in the treatment of patients with acute and chronic respiratory pathology |
|
|
Prozorova G.G., Budnevsky A.V., Chernik T.A.
|
| Vol 9, No 4 (2023) |
Myocardial infarction in young men: androgen levels and predictors of post-hospital adverse cardiovascular events |
|
|
Tkachenko V.V., Tuev A.V., Karpunina N.S., Shishkina E.A.
|
| Vol 9, No 4 (2023) |
Myocardial infarction type 1 at young age: contribution of proatherogenic factors and genetic thrombophilies |
|
|
Shushanova A.S., Gladkikh N.N., Yagoda A.V.
|
| Vol 9, No 10 (2023) |
Neurorehabilitation after a stroke: what a therapist should know |
|
|
Shishkova V.N., Shishkov V.A.
|
| Vol 10, No 9 (2024) |
New horizons in managing dyslipidemia – a risk factor for cardiovascular diseases |
|
|
Usanova A.A., Novikova E.K., Sergutova N.P., Kuzma F.M., Vasilkova A.S.
|
| Vol 9, No 4 (2023) |
New opportunities for chronic heart failure patients’ treatment: focus at dapagliflosin |
|
|
Malimon V.V., Kokorin V.A.
|
| Vol 10, No 8 (2024) |
New therapeutic opportunities of gastroprotection in cardiology |
|
|
Golendyaeva P.I., Livzan M.A., Korennova O.Y., Gaus O.V., Podolnaya S.P., Shkirinets A.V., Shukil L.V., Maltsev S.N.
|
| Vol 9, No 5 (2023) |
Non-steroid anti-inflammatory drugs in musculoskeletal pain syndrome therapy: Aspects of their effective and safe use |
|
|
Dronova Y.M., Mubarakshina O.A., Chernov S.Y.
|
| Vol 10, No 1 (2024) |
Nonsteroidal anti-inflammatory drugs in therapeutical practice |
|
|
Karateev A.E.
|
| Vol 10, No 3 (2024) |
NSAIDs gastropathies in clinician’s practice |
|
|
Bakulin I.G., Avalueva E.B., Bakulina N.V., Serkova M.Y., Berest D.G., Pavlova E.Y.
|
| Vol 10, No 3 (2024) |
Obesity in medical students: What has changed in 18 years |
|
|
Zhuchkova S.M., Busalaeva E.I., Markova T.N., Semenova V.A.
|
| Vol 10, No 8 (2024) |
Obstructive sleep apnea syndrome, diabetes mellitus and cardiovascular complications |
|
|
Kazachenko A.A., Kulikov A.N., Tanich A.V.
|
| Vol 9, No 5 (2023) |
Optimization of corticosteroid therapy for myastenia gravis |
|
|
Romanova T.V., Poverennova I.E., Persteneva N.P.
|
| Vol 11, No 4 (2025) |
Options of therapeutic effects of a complex drug in patients with external bacterial otitis |
|
|
Gurov A.V., Yushkina M.A., Muzhichkova A.V.
|
| Vol 10, No 9 (2024) |
Origin and progression of creatininemia in working-age male patients, locomotive crew workers |
|
|
Lazutkina A.Y.
|
| Vol 10, No 5 (2024) |
Orthostatic hypotension in patients with arterial hypertension and carbohydrate metabolism disorders |
|
|
Antropova O.N., Nazarova V.V., Voloshina U.E.
|
| Vol 10, No 6 (2024) |
Oxidative stress in chronic obstructive pulmonary disease: Pathogenetic and clinical aspects |
|
|
Budnevsky A.V., Avdeev S.N., Kravchenko A.Y., Vostrikova K.V.
|
| Vol 9, No 5 (2023) |
Pain in the throat from the position of a practicing otolaryngologist: Advice justified by experience |
|
|
Savranskaya K.V., Miroshnichenko N.A., Bakotina A.V., Talalaev V.N.
|
| Vol 10, No 1 (2024) |
Panniculitis: Aspects of diagnosis |
|
|
Egorova O.N., Tarasova G.M., Lila A.M.
|
| Vol 9, No 9 (2023) |
Paraneoplastic thromboendocarditis: Analysis of three cases in patients with gastric tumor lesion |
|
|
Yagoda A.V., Gladkikh N.N., Koroy P.V., Rybas A.V.
|
| Vol 10, No 7 (2024) |
Pathogenesis of virus-induced inflammation: from theory to development and implementation of a new paradigm of medicinal remedies |
|
|
Ostroumova O.D., Dubinina A.V., Telkova S.S., Gavrilova N.E., Sinitsina I.I., Malyavin A.G.
|
| Vol 9, No 7 (2023) |
Pathogenetic approaches to combined pharmacotherapy of cough syndrome |
|
|
Mubarakshina O.A., Somova M.N., Batishcheva G.A.
|
| Vol 9, No 2 (2023) |
Pathogenetic therapy in case of COVID-19: decreasing of key hyper inflammatory response factors production |
|
|
Nikolaeva S.V.
|
| Vol 9, No 6 (2023) |
Pathogenetic therapy of pulmonary hypertension |
|
|
Tsareva N.A., Khachaturov M.V., Avdeev S.N.
|
| Vol 9, No 9 (2023) |
Pathology of carbohydrate metabolism in primary hyperparathyroidism: Epidemiological and clinical characteristics |
|
|
Bibik E.E., Dobreva E.A., Eremkina A.K., Mokrysheva N.G.
|
| Vol 11, No 2 (2025) |
Patient compliance with medical recommendations: Realities and perspectives |
|
|
Kovaleva K.A., Nemyatykh O.D., Okovityi S.V.
|
| Vol 9, No 3 (2023) |
Patient with hyperuricemia and chronic kidney disease is at the doctor: Peculiarities of curation in accordance with Russian recommendations |
|
|
Maksudova A.N., Khalfina T.N., Almukhametova A.I.
|
| Vol 9, No 9 (2023) |
Patient with non-alcoholic fatty liver disease at care encounter of a therapist: Aspects of diagnostics and treatment |
|
|
Turkina S.V., Statsenko M.E., Kosivtsova M.A., Titarenko M.N., Tyshchenko I.A.
|
| Vol 11, No 1 (2025) |
Patient with overactive urinary bladder at a therapist’s appointment: algorithm of assistance |
|
|
Mubarakshina O.A., Batishcheva G.A., Dronova Y.M., Chernov S.Y.
|
| Vol 10, No 7 (2024) |
Patient with primary systemic amyloidosis: a difficult way to diagnosis |
|
|
Eremina E.Y., Strokova O.A., Zvereva S.I.
|
| Vol 9, No 6 (2023) |
Patient-oriented approach in the choice of treatment strategy in internal diseases clinic |
|
|
Verushkina A.S., Efremova E.V.
|
| Vol 9, No 4 (2023) |
Patients with cardiovascular diseases and NSAIDs intake: is there a real problem today? |
|
|
Rebrov A.P., Tyapkina M.A., Ordyakova A.A., Yupatov V.D., Kosheleva N.A., Basov I.V.
|
| Vol 11, No 6 (2025) |
Peculiarities and prognostic significance of nutritional status in fragile patients with chronic heart failure |
|
|
Moiseyeva A.Y., Al Autairi A., Chopanova A., Yakovenko V.A., Kobalava Z.D.
|
| Vol 9, No 1 (2023) |
Peculiarities of acute gouty arthritis treatment in patients with concomitant pathology. Part 1: main limitations and adverse effects of medicamentous therapy |
|
|
Lyalina V.V., Skripnichenko E.A., Borisovskaya S.V., Obyedkov R.N., Nikitin I.G.
|
| Vol 9, No 2 (2023) |
Peculiarities of acute gouty arthritis treatment in patients with concomitant pathology. Part 2: management of patients with cardiovascular, gastrointestinal, renal, liver diseases, pregnancy, also having anticoagulant therapy and patients in perioperative period |
|
|
Lyalina V.V., Skripnichenko E.A., Borisovskaya S.V., Obyedkov R.N., Nikitin I.G.
|
| Vol 9, No 10 (2023) |
Peculiarities of clinical and radiological parameters, indexes of systemic inflammation and immune status in vaccinated patients with COVID-19 |
|
|
Mineeva E.S., Demko I.V., Sobko E.A., Kruglova O.S., Kudryavtsev Y.I.
|
| Vol 10, No 5 (2024) |
Peculiarities of clinical manifestations of helicobacter pylori infection in healthcare professionals |
|
|
Luzina E.V., Lazebnik L.B., Lareva N.V., Zhilina A.A., Moskvitina A.A.
|
| Vol 9, No 7 (2023) |
Peculiarities of COVID-19 clinical course in patients with various rheumatic diseases |
|
|
Mukhamadieva V.N., Shamsutdinova N.G., Abdulganieva D.I., Adrakipov R.Z., Mukhina R.G., Dyakova E.V., Sukhorukova E.V.
|
| Vol 10, No 2 (2024) |
Peculiarities of food sensitization in patients having bronchial asthma in combination with Helicobacter pylori-associated chronic gastritis |
|
|
Pozdnyakova O.Y., Dyshekova N.V., Dokhkaeva A.Z.
|
| Vol 10, No 3 (2024) |
Peculiarities of lipid metabolism and vascular wall rigidity in ulcerative colitis patients |
|
|
Kucherova N.Y., Tsyganova Y.V., Tarasova L.V.
|
| Vol 10, No 3 (2024) |
Peculiarities of management of pregnant patients having inflammatory bowel diseases in hospital conditions: Literature review |
|
|
Knyazev O.V., Kagramanova A.V., Fadeeva N.A., Shkurko T.V.
|
| Vol 11, No 3 (2025) |
Peculiarities of metabolically healthy obesity among the population aged 45–69 |
|
|
Berezenko I.L., Filippov E.V., Volchenkova M.V.
|
| Vol 10, No 2 (2024) |
Peculiarities of multi-component subscutaneous allergen-specific immunotherapy with weed allergens performing |
|
|
Shogenova M.S., Khutueva S.K., Shogenova L.S.
|
| Vol 9, No 9 (2023) |
Peculiarities of nutrition in pregnant females with different subtypes of gestational diabetes mellitus |
|
|
Davidenko I.Y., Sorokina Y.A., Volkova N.I., Degtyareva Y.S., Kovalenko V.N., Golubev M.E.
|
| Vol 9, No 9 (2023) |
Peculiarities of outpatient glycemic profile of patients with type 2 diabetes mellitus during innovative sugar-reducing therapy combined with metformin according to flash glucose monitoring data |
|
|
Teplova A.S., Demidova T.Y., Lobanova K.G.
|
| Vol 11, No 5 (2025) |
Peculiarities of the choice of therapy for inflammatory bowel diseases associated with malignant neoplasms |
|
|
Barysheva O.Y., Golubeva A.M., Egorova K.E., Vezikova N.N., Varlamova D.D.
|
| Vol 11, No 2 (2025) |
Peculiarities of the clinical course and risk factors of long-lasting post-COVID syndrome in patients with shortness of breath |
|
|
Masalkina O.V., Polyanskaya E.A., Koziolova N.A., Chernyavina A.I.
|
| Vol 10, No 8 (2024) |
Peculiarities of the clinical course of myocardial infarction associated with malignant neoplasms of various stages and localizations at the hospital period |
|
|
Skorodumova E.G., Skorodumova E.A., Kostenko V.A., Siverina A.V.
|
| Vol 9, No 1 (2023) |
Peculiarities of the course of rheumatoid arthritis in patients with thrombocytosis and comorbid conditions |
|
|
Mazurov V.I., Melnikov E.S., Morozova K.P., Evgrafova V.E.
|
| Vol 11, No 2 (2025) |
Peculiarities of the daily profile of arterial pressure and vascular stiffness in arterial hypertension and chronic heart failure patients with senile asthenia syndrome |
|
|
Safronenko V.A., Chesnikova A.I.
|
| Vol 10, No 4 (2024) |
Pericardial sarcoma: difficulties in diagnostic search |
|
|
Tatarintseva Z.G., Palshkova A.D., Barbuhatti K.O., Babicheva O.V.
|
| Vol 9, No 7 (2023) |
Perspectives for the use of nanotechnologies in Helicobacter pylori eradication |
|
|
Bakulina N.V., Savilova I.V., Lutaenko E.A., Tsurtsumiya D.B.
|
| Vol 9, No 7 (2023) |
Perspectives of use outside diabetes, cardiac and nephroprotection |
|
|
Prikhodko V.A., Okovity S.V., Kulikov A.N.
|
| Vol 10, No 1 (2024) |
Pharmacoeconomic analysis of apixaban use for secondary thromboprophylaxis at outpatient stage among oncological patients |
|
|
Kasimova A.R., Kolbin A.S.
|
| Vol 11, No 5 (2025) |
Pharmacokinetics of indapamide in patients with arterial hypertension |
|
|
Seleznev S.V., Mylnikov P.Y., Shchulkin A.V., Yakushin S.S.
|
| Vol 10, No 9 (2024) |
Phenomenon of aging liver. Part I: Molecular-genetic, cellular, and tissue mechanisms |
|
|
Prikhodko V.A., Okovityi S.V.
|
| Vol 10, No 9 (2024) |
Phenotypic clusters of patients with heart failure and ejection fraction 40% or more: A comparative observational study |
|
|
Larina V.N., Lunev V.I.
|
| Vol 9, No 5 (2023) |
Phenotypical variability of cerebral autosomal dominant arteriopathy with subcortical infarctions and leukoencephalopathy (CADASIL): Description of three cases in one family |
|
|
Grigorieva V.N., Nesterova V.N., Ruina E.A., Sivograk A.A., Averina E.V.
|
| Vol 10, No 2 (2024) |
Polymorphic variants of renin-angiotensin-aldosterone system genes in female patients with a history of arterial hypertension during pregnancy and their association with metabolic syndrome |
|
|
Tarasova O.A., Chulkov V.S., Ektova N.A., Chulkov V.S.
|
| Vol 11, No 3 (2025) |
Polyneuropathy in Sjogren’s syndrome – a long path from symptom to diagnosis |
|
|
Ostapchuk E.S., Gorbachevsky A.V., Vorobyev A.A.
|
| Vol 10, No 4 (2024) |
Possibilities of a patient-centered approach for older age group of patients with cardiovascular comorbidity and obstructive sleep apnea syndrome |
|
|
Verushkina A.S., Efremova E.V., Shutov A.M., Serov V.A., Rebrovskaya M.M.
|
| Vol 9, No 9 (2023) |
Possibilities of early diagnosis of chronic heart failure and chronic kidney disease in patients with type 2 diabetes mellitus at the hospital stage |
|
|
Demidova T.Y., Izmailova M.Y., Antsiferov M.B.
|
| Vol 10, No 2 (2024) |
Possibilities of etiotropic and pathogenetic therapy of respiratory viral infections by means of enisamium iodide medicine |
|
|
Cherenkova O.V., Goncharova N.Y., Batishcheva G.A.
|
| Vol 11, No 1 (2025) |
Possibilities of local injection therapy for work-associated knee osteoarthritis |
|
|
Shokhin A.A., Trofimova A.S., Trofimov E.A.
|
| Vol 11, No 4 (2025) |
Possibilities of multi-vector therapy with N-acetylcysteine in the treatment of acute bronchitis |
|
|
Makarova M.A., Belevsky A.S., Krasovsky S.A.
|
| Vol 9, No 2 (2023) |
Possibilities of respiratory viral infections therapy under the conditions of etiological diversity |
|
|
Pozdnyakova M.G., Vakin V.S., Esaulenko E.V.
|
| Vol 11, No 6 (2025) |
Possibillities of secondary prevention of cardiovascular complications: focus at combination of acetylsalicylic acid with magnesium hydroxide |
|
|
Derevyanchenko M.V., Makarov L.A.
|
| Vol 11, No 3 (2025) |
Prediabetes as a therapist’s area of responsibility |
|
|
Volkova N.I., Davidenko I.Y., Repchenko D.P.
|
| 301 - 400 of 530 Items |
<< < 1 2 3 4 5 6 > >> |
